3051 - 3100 of 9148 Results
Title
Year
- Cross‐sectional and longitudinal associations between probable rapid eye movement sleep behavior disorder and impulse control disorders in Parkinson’s disease2020RESTRICTEDTitle: Cross‐sectional and longitudinal associations between probable rapid eye movement sleep behavior disorder and impulse control disorders in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 5Start Page: 757End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.14177Citation Count: 8
- Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease2013OPENTitle: Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 13End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.08.021Best OA location URL: http://doi.org/10.1016/j.parkreldis.2013.08.021Citation Count: 8
-
OPENTitle: The polarity protein Par3 regulates APP trafficking and processing through the endocytic adaptor protein NumbJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 93Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.03.022Best OA location URL: https://doaj.org/article/2fe6d6b60884479a958d8abe39fbefccCitation Count: 27
- Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET2018OPENTitle: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PETJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 652End Page: 660Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.022Citation Count: 31
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: http://americanae.aecid.es/americanae/es/registros/registro.do?tipoRegistro=MTD&idBib=3333801Citation Count: 17
- A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease2021OPENTitle: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023Best OA location URL: http://www.prd-journal.com/article/S1353802021002431/pdfCitation Count: 43
- Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke2026RESTRICTEDTitle: Prognostic Added Value of GFAP in Patients With Minor Ischemic StrokeJournal Name: European Journal of Clinical InvestigationPublisher: WileyVol: 56Issue #: 4Start Page: e70203End Page: e70203Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/eci.70203Citation Count: 0
- Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-Selective2015RESTRICTEDTitle: Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-SelectiveJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 959End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi501512mCitation Count: 65
- Transplant and risk of Parkinson disease2019RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 8
- Wearables for Parkinson's: Fast‐Paced toward Novel Outcome Measures2023OPENTitle: Wearables for Parkinson's: Fast‐Paced toward Novel Outcome MeasuresJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 11Start Page: 1988End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29608Citation Count: 1
- Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence Science2020OPENTitle: Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence ScienceJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 591End Page: 596Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.03.003Citation Count: 8
-
OPENTitle: Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page: 1785746End Page: 1785746Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/20013078.2020.1785746Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1080/20013078.2020.1785746Citation Count: 124
- Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats2016RESTRICTEDTitle: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 110Issue #:Start Page: 125End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025Citation Count: 29
-
OPENTitle: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesisJournal Name: Protein SciencePublisher: WileyVol: 32Issue #: 8Start Page: e4728End Page: e4728Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pro.4728Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10367600/pdf/PRO-32-e4728.pdfCitation Count: 2
-
RESTRICTEDTitle: Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disordersJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 257Issue #:Start Page: 174096End Page: 174096Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.pbb.2025.174096Best OA location URL: https://doi.org/10.1016/j.pbb.2025.174096Citation Count: 0
- MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression2021RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
- Fidelity of frequency and phase entrainment of circuit-level spike activity during DBS2015RESTRICTEDTitle: Fidelity of frequency and phase entrainment of circuit-level spike activity during DBSJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 2Start Page: 825End Page: 834Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/jn.00259.2015Citation Count: 48
-
OPENTitle: Genetic and clinical study of PARK7 in Japanese Parkinson's diseaseJournal Name: HeliyonPublisher: Elsevier BVVol: 10Issue #: 15Start Page: e35271End Page: e35271Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e35271Best OA location URL: https://doi.org/10.1016/j.heliyon.2024.e35271Citation Count: 7
-
OPENTitle: Prevalence of GBA p.K198E mutation in Colombian and Hispanic populationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 73Issue #:Start Page: 16End Page: 18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7528207Citation Count: 7
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 24
- Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's disease2018RESTRICTEDTitle: Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 304Issue #:Start Page: 143End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.03.008Citation Count: 31
- Media hype: Patient and scientific perspectives on misleading medical news2017RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 44
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://mhealth.amegroups.com/article/viewFile/10369/pdfCitation Count: 35
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 40
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: Impact of motor fluctuations on real-life gait in Parkinson’s patientsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 62Issue #:Start Page: 388End Page: 394Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045Best OA location URL: https://publications.aston.ac.uk/id/eprint/33121/1/1_s2.0_S0966636218302832_main.pdfCitation Count: 34
-
OPENTitle: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortiumJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1740End Page: 1744Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25600Best OA location URL: http://hdl.handle.net/11573/1383084Citation Count: 41
- Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression2025RESTRICTEDTitle: Serum L-ornithine-derived polyamines as indicators of Parkinson disease progressionJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 133Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-025-03007-wCitation Count: 1
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 29
-
OPENTitle: Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 2Start Page: 308End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51236Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51236Citation Count: 33
-
OPENTitle: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150570Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150570?id=journal-of-parkinsons-disease%2Fjpd150570Citation Count: 30
-
OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 26
-
OPENTitle: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In PersonJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 677End Page: 691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191808Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191808?id=journal-of-parkinsons-disease%2Fjpd191808Citation Count: 28
-
OPENTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 26
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 24
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 2381468320978407End Page: 2381468320978407Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 23
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page: E87End Page: E87Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 23
-
OPENTitle: Recruitment for Remote Decentralized Studies in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 371End Page: 380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212935Best OA location URL: https://escholarship.org/uc/item/0k98f47rCitation Count: 22
- Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial2023RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 13
-
OPENTitle: Understanding the Lexicon of Fatigue in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1185End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202029Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202029?id=journal-of-parkinsons-disease%2Fjpd202029Citation Count: 15
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 18
-
OPENTitle: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseasesJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 17Issue #: 823Start Page: eadr2511End Page: eadr2511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511Best OA location URL: https://pubmed.ncbi.nlm.nih.gov/41191776/Citation Count: 2
- Biomarkers for Parkinson’s Disease2011RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page: 79ps14End Page: 79ps14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458013003187Citation Count: 41
-
OPENTitle: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol:Issue #:Start Page: 1316End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.011940Best OA location URL: https://doi.org/10.1242/dmm.011940Citation Count: 40
-
OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/137434Citation Count: 24
-
OPENTitle: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change MeasuresJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 4Start Page: 665End Page: 679Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181518Best OA location URL: https://escholarship.org/uc/item/2w68g45qCitation Count: 25
-
OPENTitle: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 348End Page: 348Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01180-zBest OA location URL: https://www.nature.com/articles/s41531-025-01180-z_reference.pdfCitation Count: 4
-
OPENTitle: Remote Digital Monitoring for Medical Product DevelopmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 14Issue #: 1Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12851Citation Count: 22
-
OPENTitle: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 284End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12915Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12915Citation Count: 20